Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -3.50%13.91M | -4.55%38.28M | -49.73%4.07M | 23.28%17.38M | -47.41%2.41M | 8.17%14.42M | -12.55%40.11M | -23.11%8.09M | -17.77%14.1M | -51.02%4.59M |
Net income from continuing operations | 26.43%10.35M | -1.85%34.24M | 12.23%9.31M | 9.14%8.75M | -10.94%7.99M | -14.69%8.19M | -5.52%34.88M | -18.63%8.29M | -21.25%8.02M | -1.96%8.97M |
Operating gains losses | -154.84%-17K | -75.68%18K | 214.08%81K | -194.69%-107K | -79.37%13K | 200.00%31K | -87.39%74K | -438.10%-71K | 494.74%113K | -67.69%63K |
Depreciation and amortization | 16.42%851K | 17.23%3.22M | 24.09%891K | 24.16%848K | 19.84%749K | 1.53%731K | 5.25%2.75M | 4.51%718K | 7.05%683K | 1.13%625K |
Deferred tax | -182.28%-483K | 331.52%764K | 245.02%364K | -4.74%362K | -408.33%-549K | 267.24%587K | -205.43%-330K | -292.19%-251K | -43.28%380K | -16.13%-108K |
Other non cashItems | -57.06%1.15M | 147.00%806K | 29.51%-1.39M | 313.97%1.51M | -74.80%-2M | 159.23%2.68M | -192.85%-1.72M | -67.12%-1.97M | -83.34%365K | -1,837.29%-1.14M |
Change in working capital | -14.08%1.53M | -169.29%-2.25M | -652.83%-5.57M | 32.60%5.7M | 0.02%-4.17M | -15.92%1.78M | 195.73%3.25M | 1,231.46%1.01M | 53.94%4.3M | -743.32%-4.17M |
-Change in receivables | -910.00%-505K | 90.76%-103K | 50.04%-583K | 119.48%105K | 168.99%425K | -111.55%-50K | 56.87%-1.12M | -11.35%-1.17M | -26.53%-539K | 122.51%158K |
-Change in payables and accrued expense | -21.06%1.87M | -101.00%-59K | -402.93%-4.03M | 33.98%3.74M | -34.56%-2.15M | -29.87%2.37M | 842.58%5.91M | 989.34%1.33M | 576.27%2.79M | 7.63%-1.6M |
-Change in loans | 206.34%369K | -57.49%-1.24M | -171.21%-742K | -7.37%2.07M | 12.40%-2.23M | 77.29%-347K | -120.89%-788K | 2.36%1.04M | -25.10%2.24M | -219.98%-2.54M |
-Change in other working capital | -5.45%-213K | -12.86%-851K | -9.64%-216K | -13.61%-217K | -15.51%-216K | -12.85%-202K | -5.60%-754K | -8.84%-197K | -5.52%-191K | -3.89%-187K |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -3.50%13.91M | -4.55%38.28M | -49.73%4.07M | 23.28%17.38M | -47.41%2.41M | 8.17%14.42M | -12.55%40.11M | -23.11%8.09M | -17.77%14.1M | -51.02%4.59M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -115.73%-50.49M | -576.82%-59.16M | 64.39%-22.58M | -147.39%-24.66M | 441.99%11.48M | -492.24%-23.41M | 98.01%-8.74M | -80.39%-63.4M | 384.85%52.05M | 97.25%-3.36M |
Net investment purchase and sale | -143.93%-10.04M | -61.15%28.44M | 94.77%-928K | -129.33%-16M | -4.31%22.5M | 77.88%22.86M | 136.93%73.19M | -585.65%-17.74M | 167.54%54.56M | 221.68%23.52M |
Net proceeds payment for loan | 11.20%-40.22M | -7.47%-82.8M | 56.85%-19.19M | -678.53%-8.27M | 61.10%-10.06M | -700.53%-45.29M | 66.90%-77.04M | -21.27%-44.47M | 97.21%-1.06M | 74.32%-25.85M |
Net PPE purchase and sale | 75.45%-258K | 0.69%-4.87M | -104.75%-2.46M | 72.72%-395K | 5.96%-962K | 14.48%-1.05M | 41.96%-4.9M | 43.43%-1.2M | -23.02%-1.45M | 50.51%-1.02M |
Net other investing changes | -60.87%27K | 360.00%69K | --0 | --0 | --0 | --69K | -97.66%15K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -115.73%-50.49M | -576.82%-59.16M | 64.39%-22.58M | -147.39%-24.66M | 441.99%11.48M | -492.24%-23.41M | 98.01%-8.74M | -80.39%-63.4M | 384.85%52.05M | 97.25%-3.36M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 129.65%19.76M | -259.18%-15.57M | 42.32%54.84M | -20.98%26.85M | -265.63%-30.63M | 2.68%-66.64M | 96.18%-4.34M | 1,887.11%38.53M | 162.69%33.98M | 89.27%-8.38M |
Increase decrease in deposit | 136.73%20.57M | 9.01%3.22M | 38.07%57.98M | -68.15%30.48M | 56.48%-29.25M | 17.10%-56M | 102.65%2.95M | 1,619.70%42M | 278.23%95.71M | 13.32%-67.2M |
Net issuance payments of debt | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 | ---60M | ---- |
Net commonstock issuance | --0 | -226.25%-16.31M | 12.50%-2.53M | -160.47%-3.01M | -27.12%-764K | -2,790.17%-10M | -2,193.12%-5M | ---2.9M | ---1.16M | ---601K |
Cash dividends paid | -27.43%-813K | -8.48%-2.48M | -7.21%-610K | -7.52%-615K | -8.01%-620K | -11.15%-638K | -13.82%-2.29M | -13.12%-569K | -13.72%-572K | -14.12%-574K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 129.65%19.76M | -259.18%-15.57M | 42.32%54.84M | -20.98%26.85M | -265.63%-30.63M | 2.68%-66.64M | 96.18%-4.34M | 1,887.11%38.53M | 162.69%33.98M | 89.27%-8.38M |
Net cash flow | ||||||||||
Beginning cash position | -11.93%268.98M | 9.71%305.43M | -27.79%232.65M | -4.05%213.07M | 0.26%229.81M | 9.71%305.43M | -64.53%278.39M | 7.02%322.2M | -37.69%222.07M | -58.10%229.22M |
Current changes in cash | 77.76%-16.82M | -234.83%-36.45M | 316.59%36.33M | -80.45%19.57M | -134.11%-16.73M | -53.78%-75.62M | 105.34%27.03M | 26.05%-16.77M | 280.97%100.13M | 96.25%-7.15M |
End cash position | 9.73%252.16M | -11.93%268.98M | -11.93%268.98M | -27.79%232.65M | -4.05%213.07M | 0.26%229.81M | 9.71%305.43M | 9.71%305.43M | 7.02%322.2M | -37.69%222.07M |
Free cash flow | 2.15%13.66M | -5.08%33.41M | -76.64%1.61M | 34.39%16.99M | -59.61%1.44M | 10.47%13.37M | -5.95%35.2M | -18.02%6.89M | -20.84%12.64M | -51.17%3.57M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |